Skip to main content
Erschienen in: International Journal of Hematology 3/2014

01.03.2014 | Original Article

Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation

verfasst von: Ying Jiang, Li-ping Wan, You-wen Qin, Xiao-rui Wang, Shi-ke Yan, Kuang-cheng Xie, Chun Wang

Erschienen in: International Journal of Hematology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the correlation between chimerism status and acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation. Chimerism of peripheral blood of 124 patients was monitored at regular intervals post-transplant. The chimerism of 124 post-transplant cases of CD3+T lymphocytes, 107 cases of CD3CD56+CD16+NK lymphocytes, 49 cases of CD15+ granulocytes, and 27 cases of CD19+B lymphocytes sorted by fluorescence-activated cell sorter were analyzed by polymerase chain reaction amplification of short tandem repeats. Differences were found in the time between establishment of full donor T-cell chimerism and the occurrence of aGVHD (P = 0.035, two related samples test). Patients with ≥69 % donor chimerism on day +7 in T-cells had higher rates of aGVHD. This study may provide a rational basis for treatment with adoptive immunotherapy at an earlier time, such as day 7 after SCT, than at present to prevent aGVHD.
Literatur
1.
Zurück zum Zitat Storb R. Allogeneic hematopoietic cell transplantation: a historical perspective. Transfus Med Hemother. 2004;31:21–32.CrossRef Storb R. Allogeneic hematopoietic cell transplantation: a historical perspective. Transfus Med Hemother. 2004;31:21–32.CrossRef
2.
Zurück zum Zitat Maury S, Jouault H, Kuentz M, Vernant JP, Tulliez M, Cordonnier C, et al. Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after allogeneic stem cell transplantation. Transplantation. 2001;71(3):374–80.PubMedCrossRef Maury S, Jouault H, Kuentz M, Vernant JP, Tulliez M, Cordonnier C, et al. Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after allogeneic stem cell transplantation. Transplantation. 2001;71(3):374–80.PubMedCrossRef
3.
Zurück zum Zitat Jiang Y, Wan LP, Wang C, Yan SK, Gao YR, Jiang JL, et al. Clinical significance of dynamic monitoring of cell chimerism following allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi. 2008;29(10):667–71.PubMed Jiang Y, Wan LP, Wang C, Yan SK, Gao YR, Jiang JL, et al. Clinical significance of dynamic monitoring of cell chimerism following allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi. 2008;29(10):667–71.PubMed
4.
Zurück zum Zitat Mattsson J, Uzunel M, Remberger M, Ringdén O. Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation. Bone Marrow Transpl. 2003;32(5):477–83.CrossRef Mattsson J, Uzunel M, Remberger M, Ringdén O. Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation. Bone Marrow Transpl. 2003;32(5):477–83.CrossRef
5.
Zurück zum Zitat Balon J, Hałaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L, Piekarska A, et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transpl. 2005;35(11):1083–8.CrossRef Balon J, Hałaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L, Piekarska A, et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transpl. 2005;35(11):1083–8.CrossRef
6.
Zurück zum Zitat Tsutsumi Y, Tanaka J, Kato N, Zhang L, Mori A, Kobayasi R, et al. Analysis of mixed chimerism in patients after allogeneic stem cell transplantation using a capillary electrophoresis system. Acta Haematol. 2002;107(4):195–202.PubMedCrossRef Tsutsumi Y, Tanaka J, Kato N, Zhang L, Mori A, Kobayasi R, et al. Analysis of mixed chimerism in patients after allogeneic stem cell transplantation using a capillary electrophoresis system. Acta Haematol. 2002;107(4):195–202.PubMedCrossRef
7.
Zurück zum Zitat Jaksch M, Uzunel M, Remberger M, Sundberg B, Mattsson J. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II–IV. Clin Transpl. 2005;19(3):346–9.CrossRef Jaksch M, Uzunel M, Remberger M, Sundberg B, Mattsson J. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II–IV. Clin Transpl. 2005;19(3):346–9.CrossRef
8.
Zurück zum Zitat Valcárcel D, Martino R, Caballero D, Mateos MV, Pérez-Simón JA, Canals C, et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transpl. 2003;31(5):387–92.CrossRef Valcárcel D, Martino R, Caballero D, Mateos MV, Pérez-Simón JA, Canals C, et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transpl. 2003;31(5):387–92.CrossRef
9.
Zurück zum Zitat Nollet F, Billiet J, Selleslag D, Criel A. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transpl. 2001;28:511–8.CrossRef Nollet F, Billiet J, Selleslag D, Criel A. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transpl. 2001;28:511–8.CrossRef
10.
Zurück zum Zitat Kristt D, Stein J, Yaniv I, Klein T. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transpl. 2007;39:255–68.CrossRef Kristt D, Stein J, Yaniv I, Klein T. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transpl. 2007;39:255–68.CrossRef
11.
Zurück zum Zitat Mattsson J, Uzunel M, Remberger M, Ringden O. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation. 2001;71:433.PubMedCrossRef Mattsson J, Uzunel M, Remberger M, Ringden O. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation. 2001;71:433.PubMedCrossRef
12.
Zurück zum Zitat Li SX, Zhu HL, Guo B, Da WM. Application of short-tandem-repeat amplification and fluorescent-multiplex PCR for chimerism analysis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19(3):749–53.PubMed Li SX, Zhu HL, Guo B, Da WM. Application of short-tandem-repeat amplification and fluorescent-multiplex PCR for chimerism analysis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19(3):749–53.PubMed
13.
Zurück zum Zitat Svenberg P, Mattsson J, Ringdén O, Uzune M. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism. Bone Marrow Transpl. 2009;44(11):757–63.CrossRef Svenberg P, Mattsson J, Ringdén O, Uzune M. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism. Bone Marrow Transpl. 2009;44(11):757–63.CrossRef
14.
Zurück zum Zitat Johannes S, Alexander K, Mare S, Gerhard E, Martin B. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol Immunother. 2005;54:1043–58.CrossRef Johannes S, Alexander K, Mare S, Gerhard E, Martin B. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol Immunother. 2005;54:1043–58.CrossRef
15.
Zurück zum Zitat Perez-Simon JA, Caballero D, Diez-Campelo M, Lopen-Perez R, Mateos G, Canizo C, et al. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Leukemia. 2002;16:1423–31.PubMedCrossRef Perez-Simon JA, Caballero D, Diez-Campelo M, Lopen-Perez R, Mateos G, Canizo C, et al. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Leukemia. 2002;16:1423–31.PubMedCrossRef
16.
Zurück zum Zitat Rupa-Matysek J, Lewandowski K, Nowak W, Sawiński K, Gil L, Komarnicki M. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation. Transpl Proc. 2011;43(5):1915–23.CrossRef Rupa-Matysek J, Lewandowski K, Nowak W, Sawiński K, Gil L, Komarnicki M. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation. Transpl Proc. 2011;43(5):1915–23.CrossRef
17.
Zurück zum Zitat Childs R, Clave E, Contenin N, Jayasekera D, Hensel N, Leitman S, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full fonor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234–41.PubMed Childs R, Clave E, Contenin N, Jayasekera D, Hensel N, Leitman S, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full fonor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234–41.PubMed
18.
Zurück zum Zitat Lim ZY, Pearce L, Ingram W, Ho AYL, Mufti GJ, Pagliuca A. Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative. Bone Marrow Transpl. 2008;41(6):587–8.CrossRef Lim ZY, Pearce L, Ingram W, Ho AYL, Mufti GJ, Pagliuca A. Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative. Bone Marrow Transpl. 2008;41(6):587–8.CrossRef
19.
Zurück zum Zitat Besien K, Dew A, Lin S, et al. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymph. 2009;50(11):1809–17.CrossRef Besien K, Dew A, Lin S, et al. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymph. 2009;50(11):1809–17.CrossRef
20.
Zurück zum Zitat Mossallam GI, Kamel AM, Storer B, Martin PJ. Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2009;15(3):352–9.CrossRef Mossallam GI, Kamel AM, Storer B, Martin PJ. Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2009;15(3):352–9.CrossRef
21.
Zurück zum Zitat Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, et al. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. Br J Haematol. 2005;130:733–9.PubMedCrossRef Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, et al. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. Br J Haematol. 2005;130:733–9.PubMedCrossRef
22.
Zurück zum Zitat Mohty M, Avinens O, Faucher C, Viens P, Blaise D, Elia JF. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Haematologica. 2007;92(7):1004–6.PubMedCrossRef Mohty M, Avinens O, Faucher C, Viens P, Blaise D, Elia JF. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Haematologica. 2007;92(7):1004–6.PubMedCrossRef
23.
Zurück zum Zitat Baron F, Baker JE, Storb R, Gooley TA, Sandmaier BM, Maris MB, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood. 2004;104(8):2254–62.PubMedCrossRef Baron F, Baker JE, Storb R, Gooley TA, Sandmaier BM, Maris MB, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood. 2004;104(8):2254–62.PubMedCrossRef
24.
Zurück zum Zitat Alcoceba M, Balanzategui A, Díez-Campelo M, Martín-Jiménez P, Sarasquete ME, Chillón MC, et al. Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting. Transplantation. 2008;86(7):983–90.PubMedCrossRef Alcoceba M, Balanzategui A, Díez-Campelo M, Martín-Jiménez P, Sarasquete ME, Chillón MC, et al. Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting. Transplantation. 2008;86(7):983–90.PubMedCrossRef
25.
Zurück zum Zitat Miura Y, Tanaka J, Toubai T, Tsutsumi Y, Kato N, Hirate D, et al. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation. Bone Marrow Transpl. 2006;37(9):837–43.CrossRef Miura Y, Tanaka J, Toubai T, Tsutsumi Y, Kato N, Hirate D, et al. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation. Bone Marrow Transpl. 2006;37(9):837–43.CrossRef
26.
Zurück zum Zitat Bacigalupo A, Lamparelli T, Milone G, et al. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day +7 after alternative donor transplants. Bone Marrow Transpl. 2010;45:385–91.CrossRef Bacigalupo A, Lamparelli T, Milone G, et al. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day +7 after alternative donor transplants. Bone Marrow Transpl. 2010;45:385–91.CrossRef
Metadaten
Titel
Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation
verfasst von
Ying Jiang
Li-ping Wan
You-wen Qin
Xiao-rui Wang
Shi-ke Yan
Kuang-cheng Xie
Chun Wang
Publikationsdatum
01.03.2014
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 3/2014
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1510-5

Weitere Artikel der Ausgabe 3/2014

International Journal of Hematology 3/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.